Sylvia Health ApS
CVR 44249774 · Private limited company (ApS) · Active · Medium risk
Sylvia Health ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -315k and a net result of DKK -132k. CEO: Andrew John Stretton, Nikolaj Ulrik Friis.
Bankruptcy risk for Sylvia Health ApS
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44249774
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- c/o BioInnovation Institute (BII), Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- Lokal Revision
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -15.2% |
| Current ratio | 15% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 1.0m | DKK 1.4m |
| Net profit | DKK -132k | DKK 560k |
| Equity | DKK -315k | DKK 600k |
| Total assets | DKK 2.1m | DKK 775k |
| Cash | DKK 47k | DKK 36k |
| Short-term debt | DKK 1.7m | DKK 14k |
| Avg. employees | 2 | 2 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Lokal Revision.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 154 | ||
| 21 Aug 2023 – 31 Dec 2024 | 83 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Andrew John Stretton | Current | |
| CEO | Nikolaj Ulrik Friis | Current | |
| Owner (50%) | Nufriis ApS | Current | |
| Owner (50%) | Stretton ApS | Current | |
| Founder | Nufriis ApS | Current | |
| Founder | Stretton ApS | Current |
The CEOs' other companies
Andrew John Stretton – 1 other companies
- Stretton ApS Active
Nikolaj Ulrik Friis – 1 other companies
- Nufriis ApS Active
Address history (2 moves)
| c/o BioInnovation Institute (BII), Ole Maaløes Vej 3, 2200 København N | |
| c/o KU Lighthouse, Tagensvej 16A, 2200 København N | |
| Løgstørgade 29, 3. tv, 2100 København Ø |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Sylvia Health ApS
Has Sylvia Health ApS gone bankrupt?
No, Sylvia Health ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Sylvia Health ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of Sylvia Health ApS?
Andrew John Stretton, Nikolaj Ulrik Friis are the CEOs of Sylvia Health ApS.
Who is the auditor of Sylvia Health ApS?
Sylvia Health ApS most recently used Lokal Revision.
When was Sylvia Health ApS founded?
Sylvia Health ApS was founded on 21 August 2023.
What is the equity of Sylvia Health ApS?
Equity was DKK -315k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.